FDA-Approved Randomized Controlled Feasibility Study Finds InGeneron\'s Regenerative Cell Therapy to Significantly Reduce Pain and Improve Shoulder Function Over Corticosteroid Injection to Address Symptomatic Partial-Thickness Rotator Cuff Tears